These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35208906)

  • 1. Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics.
    Breton J; Galmiche M; Déchelotte P
    Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay of Microbiome Dysbiosis and Cardiovascular Disease.
    Zaher A; Elsaygh J; Peterson SJ; Weisberg IS; Parikh MA; Frishman WH
    Cardiol Rev; 2024 Apr; ():. PubMed ID: 38666794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Uusitupa HM; Rasinkangas P; Lehtinen MJ; Mäkelä SM; Airaksinen K; Anglenius H; Ouwehand AC; Maukonen J
    Nutrients; 2020 Mar; 12(4):. PubMed ID: 32218248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
    Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
    mBio; 2017 May; 8(3):. PubMed ID: 28536285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and obesity: Impact of antibiotics and prebiotics and potential for musculoskeletal health.
    Klancic T; Reimer RA
    J Sport Health Sci; 2020 Mar; 9(2):110-118. PubMed ID: 32099719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
    Chen J; Thomsen M; Vitetta L
    J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.
    Gasmi A; Mujawdiya PK; Pivina L; Doşa A; Semenova Y; Benahmed AG; Bjørklund G
    Curr Med Chem; 2021; 28(4):827-839. PubMed ID: 32693755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbiota-gut-brain axis in obesity.
    Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.